Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Mark Warren

6PUBLICATIONS

19CO-AUTHORS

Immunogenetics (incl. genetic immunology)Prosthetics and orthoticsPharmaceutical delivery technologiesExercise physiologyFood properties (incl. characteristics and health benefits)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Apr 01, 2024

Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study.

Elena A Christofides, Orlando Puente, Paul Norwood

|Apr 24, 2023

Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism.

Nelson B Watts, John P Bilezikian, Henry G Bone

|Mar 09, 2021

Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2.

Mark Warren, Bruce Bode, Jang I Cho

|Apr 01, 2020

Semaglutide improves health-related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6).

Esteban Jódar, Marie Michelsen, William Polonsky

|May 17, 2018

Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials.

Bo Ahrén, Stephen L Atkin, Guillaume Charpentier

|Apr 25, 2018

Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: Pooled analysis of the SUSTAIN 1-5 trials.

Mark Warren, Louis Chaykin, David Trachtenbarg

Pageof 1

Frequent Collaborators

1 joint publications

Bo Ahrén

1 joint publications

Stephen L Atkin

1 joint publications

Lawrence A Leiter

1 joint publications

Nelson B Watts

1 joint publications

John P Bilezikian

1 joint publications

Henry G Bone

1 joint publications

Bart L Clarke

1 joint publications

Douglas Denham

1 joint publications

Michael A Levine

1 joint publications

Michael Mannstadt

Frequent Collaborators

1 joint publications

Bo Ahrén

1 joint publications

Stephen L Atkin

1 joint publications

Lawrence A Leiter

1 joint publications

Nelson B Watts

Top Related Videos

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate

Published on : Jun 25, 2019

Generation of Hypoparathyroid Rats <em>via</em> Carbon-Nanoparticle-Assisted Parathyroidectomy

Generation of Hypoparathyroid Rats <em>via</em> Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on : Jul 14, 2023

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on : Jun 11, 2012

See more related videos

Top Related Videos

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate

Published on : Jun 25, 2019

Generation of Hypoparathyroid Rats <em>via</em> Carbon-Nanoparticle-Assisted Parathyroidectomy

Generation of Hypoparathyroid Rats <em>via</em> Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on : Jul 14, 2023

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on : Jun 11, 2012

See more related videos